These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1838257)
61. Antibody recognition of the tumor-specific b3-a2 junction of bcr-abl chimeric proteins in Philadelphia-chromosome-positive leukemias. van Denderen J; ten Hacken P; Berendes P; Zegers N; Boersma W; Grosveld G; van Ewijk W Leukemia; 1992 Nov; 6(11):1107-12. PubMed ID: 1434792 [TBL] [Abstract][Full Text] [Related]
62. Influence of BCR/ABL fusion proteins on the course of Ph leukemias. Telegeev GD; Dubrovska AN; Dybkov MV; Maliuta SS Acta Biochim Pol; 2004; 51(3):845-9. PubMed ID: 15448745 [TBL] [Abstract][Full Text] [Related]
63. Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Mes-Masson AM; McLaughlin J; Daley GQ; Paskind M; Witte ON Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9768-72. PubMed ID: 3540951 [TBL] [Abstract][Full Text] [Related]
64. Conformational effects of substituting amino acids for glutamine-61 on the central transforming region of the P21 proteins. Pincus MR; Brandt-Rauf PW; Carty RP; Lubowsky J; Avitable M; Gibson KD; Scheraga HA Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8375-9. PubMed ID: 3120190 [TBL] [Abstract][Full Text] [Related]
65. [The Philadelphia chromosome: from the gene to therapeutic methods]. Pérez-Losada J; González-Sarmiento R; Sánchez-García I Sangre (Barc); 1998 Apr; 43(2):127-35. PubMed ID: 9656774 [No Abstract] [Full Text] [Related]
66. Standpoint on imprinting of BCR and ABL. Fioretos T; Heisterkamp N; Groffen J Leukemia; 1995 Apr; 9(4):743-4. PubMed ID: 7723414 [TBL] [Abstract][Full Text] [Related]
67. Molecular insights into the Philadelphia translocation. Heisterkamp N; Groffen J Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600 [TBL] [Abstract][Full Text] [Related]
68. Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients. Konopka JB; Clark S; McLaughlin J; Nitta M; Kato Y; Strife A; Clarkson B; Witte ON Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4049-52. PubMed ID: 3012546 [TBL] [Abstract][Full Text] [Related]
69. The role of myc in transformation by BCR-ABL. Sawyers CL Leuk Lymphoma; 1993; 11 Suppl 1():45-6. PubMed ID: 8251915 [TBL] [Abstract][Full Text] [Related]
71. Conformational effects of environmentally induced, cancer-related mutations in the p53 protein. Brandt-Rauf PW; Monaco R; Pincus MR Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9262-6. PubMed ID: 7937752 [TBL] [Abstract][Full Text] [Related]
72. The bcr-abl gene in chronic myelogenous leukaemia. Sawyers CL Cancer Surv; 1992; 15():37-51. PubMed ID: 1451113 [TBL] [Abstract][Full Text] [Related]
73. An activating amino acid substitution in the c-abl oncogene protein fails to produce a local conformational change. Brandt-Rauf PW; Bomzer G; Belford D; Pincus MR J Protein Chem; 1991 Aug; 10(4):437-41. PubMed ID: 1838257 [TBL] [Abstract][Full Text] [Related]
74. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. McWhirter JR; Galasso DL; Wang JY Mol Cell Biol; 1993 Dec; 13(12):7587-95. PubMed ID: 8246975 [TBL] [Abstract][Full Text] [Related]
75. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Pendergast AM; Muller AJ; Havlik MH; Maru Y; Witte ON Cell; 1991 Jul; 66(1):161-71. PubMed ID: 1712671 [TBL] [Abstract][Full Text] [Related]
76. Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein. Brandt-Rauf PW; Pincus MR; Chen JM J Protein Chem; 1989 Dec; 8(6):749-56. PubMed ID: 2576207 [TBL] [Abstract][Full Text] [Related]